SKI Market

Indian Indices

Nifty

25,839.65 -120.90
(-0.47%)

Sensex

84,666.28 -436.41
( -0.51%)

Bank Nifty

59,222.35 -16.20
( -0.03%)

Nifty IT

38,130.60 -460.10
( -1.19%)

Global Indices

Nasdaq

47,765.34 -210.65
(-0.44%)

Dow Jones

6,868.55 -22.85
(-0.33%)

Hang Seng

50,689.00 107.06
(0.21%)

Nikkei 225

9,640.52 -4.57
(-0.05%)

Forex

USD-INR

89.90 -0.09
(-0.10%)

EUR-INR

104.66 -0.26
(-0.25%)

GBP-INR

119.79 -0.26
(-0.22%)

JPY-INR

0.58 0.00
(-0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

62.6776943

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

63.73

3463.76

EPS(TTM)

Face Value()

Div & Yield %

5.42

0.03

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	819.81	806.67	690.62	779.16	487.70	378.84
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	819.81	806.67	690.62	779.16	487.70	378.84
Other Income	3.62	2.18	2.57	3.10	3.73	5.79
Stock Adjustments	24.91	-0.57	33.39	19.39	-14.29	10.91
Total Income	848.34	808.28	726.58	801.65	477.14	395.54
EXPENDITURE :
Raw Materials	399.62	389.32	365.21	431.35	236.00	190.45
Power & Fuel Cost	18.46	17.61	15.24	11.00	9.94	8.23
Employee Cost	127.19	109.67	86.73	85.61	66.22	58.59
Other Manufacturing Expenses	29.25	28.43	24.67	27.42	18.20	15.93
Selling & Administrative Expenses	122.19	105.28	87.63	77.97	45.93	54.08
Miscellaneous Expenses	11.62	8.48	9.88	17.16	13.20	10.35
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	708.33	658.79	589.36	650.51	389.49	337.63
Operating Profit	140.01	149.48	137.22	151.14	87.65	57.90
Interest	24.52	16.79	8.22	5.37	13.63	13.91
Gross Profit	115.49	132.69	129.00	145.77	74.02	43.99
Depreciation	21.06	17.02	22.28	18.93	16.31	13.86
Profit Before Tax	94.43	115.67	106.72	126.84	57.71	30.13
Tax	18.74	26.37	28.21	32.15	17.20	8.31
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	5.75	3.17	-1.19	-1.15	-3.72	-0.87
Reported Net Profit	69.93	86.14	79.70	95.84	44.23	22.69
Extraordinary Items	0.09	-1.67	0.02	0.05	0.02	0.01
Adjusted Net Profit	69.84	87.81	79.68	95.79	44.21	22.68
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.26	0.00
P & L Balance brought forward	352.46	267.29	188.55	93.68	49.58	27.36
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1.00	0.97	0.97	0.97	0.39	0.47
P & L Balance carried down	421.39	352.46	267.29	188.55	93.68	49.58
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	10.00	10.00	10.00	10.00	10.00	5.00
Dividend Per Share(Rs)	0.10	0.10	0.10	0.10	0.10	0.05
Earnings Per Share-Unit Curr	6.97	8.59	8.22	9.89	4.56	2.34
Earnings Per Share(Adj)-Unit Curr	6.97	8.59	8.22	9.89	4.56	2.34
Book Value-Unit Curr	59.96	53.11	35.88	27.76	17.89	13.34
Book Value(Adj)-Unit Curr	59.96	53.11	35.88	27.76	17.89	13.34

25,839.65 -120.90 (-0.47%)

84,666.28 -436.41 ( -0.51%)

59,222.35 -16.20 ( -0.03%)

38,130.60 -460.10 ( -1.19%)

47,765.34 -210.65 (-0.44%)

6,868.55 -22.85 (-0.33%)

50,689.00 107.06 (0.21%)

9,640.52 -4.57 (-0.05%)

89.90 -0.09 (-0.10%)

104.66 -0.26 (-0.25%)

119.79 -0.26 (-0.22%)

0.58 0.00 (-0.32%)